IP Library Assignment 067454/0047
Patent Assignment
Reel/Frame 067454/0047

Confirmatory Assignment

Recorded: 2024-05-17 Pages: 4
Assignor
SOLVIAS AG
Executed: 2024-03-20
Assignee
ERASCA, INC.
3115 MERRYFIELD ROW, SUITE 300, SAN DIEGO, CALIFORNIA, 92121
Covered Property (1)
POLYMORPHIC FORMS OF (S)-N-(3-BROMO-2-FLUOROPHENYL)-7-((4-METHYLPIPERAZIN-1-YL)METHYL)-7,8-DIHYDRO-[1,4]DIOXINO[2,3-g]QUINAZOLIN-4-AMINE AS EGFR INHIBITORS
Application: 18/614,458 →
Publication: US 2024/0287088
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 30, 2025
From: ERASCA, INC.
To: KATMAI PHARMACEUTICALS, INC.
Reel/Frame 071877/0049 →